Financials

  • Market Capitalization 13.13 M
  • Employee 6
  • Founded 2011
  • CEO N/A
  • Website www.phiopharma.com
  • Headquarter Delaware, United States
  • FIGI BBG0024FKD97
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.72
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4699
GTBP
GT Biopharma, Inc. - Common Stock
0.30 USD0.00%+3.45%0.00%-67.74%13.53 M USD
4702
KALA
KALA BIO, Inc. - Common Stock
0.69 USD-13.75%-15.85%0.00%-94.25%13.34 M USD
4709
MBRX
Moleculin Biotech, Inc. - Common Stock
0.65 USD-5.80%+8.33%-51.13%-79.37%12.66 M USD
4720
QNRX
Quoin Pharmaceuticals Ltd - American Depositary Shares
6.12 USD+18.60%+13.33%+45.37%-34.33%12.29 M USD

Frequently asked questions about Phio Pharmaceuticals Corp. Common Stock

What is the Phio Pharmaceuticals Corp. Common Stock stock price today?

The current price of Phio Pharmaceuticals Corp. Common Stock (PHIO) is 1.13. Over the past 24 hours, the stock has changed by +0.89%. Follow the PHIO chart for real-time price dynamics.

What is the stock ticker of Phio Pharmaceuticals Corp. Common Stock?

Phio Pharmaceuticals Corp. Common Stock trades under the ticker PHIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Phio Pharmaceuticals Corp. Common Stock stock going up?

PHIO has changed by -5.04% over the last week, +16.49% over the last month, and -5.04% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Phio Pharmaceuticals Corp. Common Stock?

Phio Pharmaceuticals Corp. Common Stock currently has a market capitalization of 13.13 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Phio Pharmaceuticals Corp. Common Stock earnings last quarter?

Last quarter, Phio Pharmaceuticals Corp. Common Stock reported earnings of -0.36 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Phio Pharmaceuticals Corp. Common Stock revenue for the last quarter?

Phio Pharmaceuticals Corp. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Phio Pharmaceuticals Corp. Common Stock net income for the last quarter?

Phio Pharmaceuticals Corp. Common Stock reported net income of -4.14 M for the last quarter. The previous quarter showed -4 M, which means net income changed by -3.37%.

How many employees does Phio Pharmaceuticals Corp. Common Stock have?

As of the latest available data, Phio Pharmaceuticals Corp. Common Stock has 6 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Phio Pharmaceuticals Corp. Common Stock stock?

You can buy Phio Pharmaceuticals Corp. Common Stock (PHIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Phio Pharmaceuticals Corp. Common Stock stock?

Investing in Phio Pharmaceuticals Corp. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PHIO chart and related analysis on metatrader.com as part of your research.

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

News